thromboxanes has been researched along with Phlegmasia Alba Dolens in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Foegh, ML; Helfrich, GB; Ramwell, PW; Schreiner, GE; Winchester, JF; Zmudka, M | 1 |
Nilsson, IM; Saldeen, P; Saldeen, T | 1 |
Cohn, LS; Klotz, TA; Zipser, RD | 1 |
Fuccella, LM | 1 |
Müller, B; Stürzebecher, S; Witt, W | 1 |
Heran, CL; Schumacher, WA | 1 |
Gréen, K; Johnsson, H; Vesterqvist, O | 1 |
Krause, FJ | 1 |
1 review(s) available for thromboxanes and Phlegmasia Alba Dolens
Article | Year |
---|---|
Clinical pharmacology of inhibitors of platelet aggregation.
Topics: Bleeding Time; Blood Coagulation Disorders; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Coronary Disease; Dose-Response Relationship, Drug; Epoprostenol; Humans; In Vitro Techniques; Ischemia; Platelet Aggregation; Thrombophlebitis; Thromboxanes | 1979 |
7 other study(ies) available for thromboxanes and Phlegmasia Alba Dolens
Article | Year |
---|---|
Aspirin inhibition of thromboxane release in thrombosis and renal transplant rejection.
Topics: Aspirin; Graft Rejection; Humans; Kidney Transplantation; Thrombophlebitis; Thromboxane B2; Thromboxanes | 1982 |
Increased synthesis of thromboxane B2 and 6-keto-PGF1 alpha in hand veins from patients with deep venous thrombosis.
Topics: Adolescent; Adult; Aged; Cerebrovascular Disorders; Female; Fibrinolysis; Hand; Humans; Male; Middle Aged; Prostaglandins F; Thrombophlebitis; Thromboxane B2; Thromboxanes; Veins | 1983 |
Urinary excretion of thromboxane B2 in patients with venous thromboembolic disease.
Topics: Angiography; Aspirin; Humans; Lung; Platelet Function Tests; Pulmonary Embolism; Radioimmunoassay; Thrombophlebitis; Thromboxane B2; Thromboxanes | 1984 |
Synergistic antiplatelet and antithrombotic effects of a prostacyclin analogue (iloprost) combined with a thromboxane antagonist (sulotroban) in guinea pigs and rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cardiovascular Agents; Collagen; Drug Synergism; Epoprostenol; Fibrinolytic Agents; Guinea Pigs; Iloprost; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Rats; Sulfonamides; Thrombocytopenia; Thrombophlebitis; Thromboxanes | 1988 |
Effect of thromboxane receptor antagonists on venous thrombosis in rats.
Topics: Animals; Bleeding Time; Blood Platelets; Drug Synergism; Heparin; Male; Partial Thromboplastin Time; Phenylacetates; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thrombophlebitis; Thromboxane A2; Thromboxanes | 1989 |
Thromboxane and prostacyclin formation in patients with deep vein thrombosis.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Blood Platelets; Epoprostenol; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Thrombophlebitis; Thromboxane A2; Thromboxane B2; Thromboxanes; Time Factors | 1987 |
[Modification of prostaglandin metabolism (increased susceptibility to thrombosis?) by roentgen contrast media in arteriography].
Topics: Adult; Aged; Angiography; Arteriosclerosis; Contrast Media; Female; Humans; Iopamidol; Leg; Male; Middle Aged; Prostaglandins; Risk; Thrombophlebitis; Thromboxanes | 1987 |